LSKL TFA
Product Specifications
CAS Number
2828433-17-4
Target
TGF-beta/Smad
Related Pathways
Stem Cells
Purity
0.9933
Bioactivity
LSKL TFA (H-Leu-Ser-Lys-Leu-NH2 TFA) is a LAP-TGFβ derivative and a TGF-β1 antagonist that can cross the blood-brain barrier, inhibits the binding of TSP-1 to LAP and reduces renal interstitial fibrosis and liver fibrosis, inhibits subarachnoid fibrosis by inhibiting TSP-1-mediated TGF-β1 activity, prevents the occurrence of chronic hydrocephalus and improves long-term neurocognitive deficits after subarachnoid hemorrhage.
Smiles
O=C(O)C(F)(F)F.CC(C)C[C@@H](C(N)=O)NC([C@H](CCCCN)NC([C@H](CO)NC([C@@H](N)CC(C)C)=O)=O)=O
Molecular Formula
C23H43F3N6O7
Molecular Weight
572.62
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
037091-Biotin 200 µL
IQSEC3, NT (IQSEC3, KIAA1110, IQ motif and SEC7 domain-containing protein 3) (Biotin) discontinued
Sign In for Pricing
View Details 
413537-01 1 mg
2- (3,7,11,15-Tetramethylhexadecyl) -5,6,7,8-tetrahydronaphthalene-1,4-dione
Sign In for Pricing
View Details 413537-02 5 mg
2- (3,7,11,15-Tetramethylhexadecyl) -5,6,7,8-tetrahydronaphthalene-1,4-dione
Sign In for Pricing
View Details 
GTR15162637 1 Vial
Lentiviral human OTUB1 shRNA (UAS) - Lentiviral human OTUB1 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details